Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia.

Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia.

Item
http://www.wikidata.org/entity/Q43055297
Polyphenols: a Promising Nutritional Approach to Prevent or Reduce the Progression of Prehypertension.Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trialClinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet.Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trialGenetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled StudyNutraceuticals: Definition and Epidemiological Rationale for Their Use in Clinical Practice.Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study.Vitamin D, parathyroid hormone and cardiovascular risk: the good, the bad and the ugly.The Age of Nutraceuticals: Exploring New Therapeutic Targets.Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension.Effects of a Novel Fixed Combination of Nutraceuticals on Serum Uric Acid Concentrations and the Lipid Profile in Asymptomatic Hyperuricemic Patients : Results from the PICONZ-UA Study.Wild Plant-Based Functional Foods, Drugs, and NutraceuticalsNutraceuticals for Blood Pressure Control in Patients with High-Normal or Grade 1 Hypertension
P2860

Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia.

Item
http://www.wikidata.org/entity/Q43055297
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@en
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@nl
type
label
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@en
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@nl
prefLabel
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@en
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Effects of nutraceuticals on p ...... individuals with dyslipidemia.
@en
P2093
P304
P31
P356
10.1097/HJH.0B013E3283395208
P433
P478
P50
P577
P698
P921